global-biotechnology-reagents-market-industry
Published

APR 2018

Biotechnology Reagents Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecasts (2018 - 2023)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

The global biotechnology reagents market is expected to witness a CAGR of 7.4% during the forecast period of 2018-2023, and is expected to be valued at USD 87.2 billion by the end of 2022. Owing to a large number of companies investing in the manufacturing of reagents, the demand for these reagents is growing at a robust pace.

Increasing Interest in Stem Cell Research

Stem cells are now being considered as a treatment option for regenerative and for lifesaving therapies. Research on the ethically sourced adult stem cells has been garnering popularity since 2010. The drug manufacturing companies have initiated stem cell research and several players in the pharmaceutical industry are using these cells to test the toxicity of drugs, which helps them identify new therapies. These researchers and pharmaceutical companies are studying stem cells for basic research, toxicity test, drug discovery, and future applications. A wide range of reagents, such as stem cell culture media, laboratory reagents, etc., are necessary to meet the stem cell culture needs. With the booming stem cell research, it is anticipated that the demand for biotechnology reagents will grow over the forecast period.

The other factors that also drive the market are - exponential rise of the biotechnology industry across the globe, significant investments by private players in R&D, and rise in the number of market players.

High Cost of Reagents

The reagents used for life science research usually involve high costs. Hence, availability of the services that require reagents in the developing regions is often limited by the high costs associated with reagents. To counter this issue, various measures are being undertaken, such as manufacturing of low-cost reagents. Local development of reagents may become a time-consuming process, as most of the reagents manufactured by the local companies may result in low-quality reagents. Therefore, high costs act as a barrier for the market studied.

Stringent government regulations for the approval of reagents are expected to lead to a fall in the demand for reagents and lack of skilled personnel to handle the reagents, thus hampering the growth of the market studied.

North America Dominates the Biophotonics Market

North America dominates the global biotechnology reagents market and incurs the highest expenditure for global R&D. The United States accounted for the largest share of 73%, in 2016. The North American segment is on a rise, because of the ongoing research in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of biotechnology reagents in the market. Due to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.

                         
Key Developments in the Market

  • August 2016: GE Healthcare expanded its cell therapy portfolio, with the license of STEMCELL Technologies T-Cell reagents.

Major Players: GE Healthcare, Siemens Healthcare, Abbott, Waters Corp., Beckman Coulter, Roche, Lonza, EMD Biosciences, Bio Rad Laboratories, Sigma Aldrich, and Olympus Biotech, among others

Reasons to Purchase this Report

  • Current and future biotechnology reagents market outlook in the developed and emerging markets.
  • Analyzing various perspectives of the market, with the help of Porter’s five forces analysis.
  • The segment that is expected to dominate the market.
  • The regions that are expected to witness the fastest growth during the forecast period.
  • Identify the latest developments, market shares, and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet (in excel)

Customization of the Report

  • This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?